<DOC>
	<DOCNO>NCT00126074</DOCNO>
	<brief_summary>The purpose study demonstrate ability tedisamil convert atrial fibrillation flutter normal sinus rhythm ( NSR ) female patient .</brief_summary>
	<brief_title>Intravenous Tedisamil Rapid Conversion Atrial Fibrillation Flutter Normal Sinus Rhythm Female Subjects</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Atrial Flutter</mesh_term>
	<mesh_term>Tedisamil</mesh_term>
	<criteria>Willing sign inform consent screen examination perform study drug administer Females &gt; 18 year age Subjects document ( 60 second rhythm strip ) symptomatic atrial fibrillation flutter ( duration &gt; 3 hour &lt; 45 day ) time randomization Subjects distress hemodynamically stable ( supine systolic blood pressure &gt; 90 mmHg diastolic blood pressure &lt; 105 mmHg ) Pregnancy lactation Acute myocardial infarction cerebrovascular accident Coronary syndrome congestive heart failure ( CHF ) New York Heart Association ( NYHA ) IV Lifethreatening ventricular arrhythmia electrocardiogram ( ECG ) abnormalities Concurrent antiarrhythmic treatment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>Atrial fibrillation , atrial flutter , anti-arrhythmic agent , conversion normal sinus rhythm</keyword>
</DOC>